| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2395136A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392554A1 Inhibitors of thrombin induced platelet aggregation |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/27/2001 | EP1110556A1 Preventives/remedies for multiple organ failure |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
| 06/27/2001 | EP1109822A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses |
| 06/27/2001 | EP1109784A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
| 06/27/2001 | EP1109571A2 Methods of treating hypertension and compositions for use therein |
| 06/27/2001 | EP1109554A2 Pipecolic acid derivatives for vision and memory disorders |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP1109537A1 Immediate release tablet |
| 06/27/2001 | EP0973544B1 Immunotolerant prothrombin complex preparation |
| 06/27/2001 | EP0733046B1 benzoyl guanidines, their production and their use in medicaments |
| 06/27/2001 | EP0690720B1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/27/2001 | CN1301269A Template associated NPY Y2-receptor agonists |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 06/27/2001 | CN1301179A Hemoglobin-polysaccharide conjugates |
| 06/27/2001 | CN1301173A Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1301131A Dipeptide apoptosis inhibitors and the use thereof |
| 06/27/2001 | CN1300622A Chinese medicine for treating injury |
| 06/27/2001 | CN1300594A Ginsengdiol histsaponin and application of its composition in treating hematopathy |
| 06/27/2001 | CN1067722C Adenoviral vectors |
| 06/27/2001 | CN1067590C Protein granule composition suitable for intravenous injection |
| 06/27/2001 | CN1067589C Protein granules suitable for intravenous injection |
| 06/27/2001 | CN1067569C Zhixuening-medicine for stopping bleeding |
| 06/27/2001 | CN1067558C Blood-enriching agent and preparation thereof |
| 06/26/2001 | US6252113 O-etherification of p-(2-methoxyethyl)-phenol with aqueous epichlorohydrin, evaporation of excess epichlorohydrin, distillation, then amination with isopropylamine to yield metoprolol product |
| 06/26/2001 | US6251921 Administering thrombin inhibiting diamine compound to mammal |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251902 Dipeptide derivatives as growth hormone secretagogues |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251393 Conformation-specific anti-von Willebrand Factor antibodies |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044294A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | WO2001044284A2 Chimeric natriuretic peptides |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044258A1 Novel heterocycles |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044172A1 Salicylamides as serine protease and factor xa inhibitors |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043765A2 Method for localized administration of fibrinolytic metalloproteinases |
| 06/21/2001 | WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | WO2001043720A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | WO2001043691A2 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | WO2001012787A3 Chimeric dna/rna ribozymes containing propanediol |
| 06/21/2001 | WO2000061191A9 Heat stable coated colloidal iron oxides |
| 06/21/2001 | CA2395585A1 Chimeric natriuretic peptides |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2394650A1 Novel heterocycles |
| 06/21/2001 | CA2394639A1 Salicylamides as serine protease and factor xa inhibitors |
| 06/21/2001 | CA2394613A1 Method for localized administration of fibrinolytic metalloproteinases |
| 06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394544A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394504A1 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394416A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | CA2394167A1 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | CA2393808A1 Anti-cancer synthetic oligonucleotides |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/20/2001 | EP1108428A2 Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108427A2 Compositions for and uses thereof for altering gene expression with phenylacetate and derivatives thereof |
| 06/20/2001 | EP1108051A2 Inducible expression system |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1107996A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107980A1 CRYSTALLINE FORMS OF EtO 2?C-CH 2?-($i(R))Cgl-Aze-Pab-OH |
| 06/20/2001 | EP1107968A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one |
| 06/20/2001 | EP1107959A2 Quinazoline derivatives as medicaments |
| 06/20/2001 | EP1107954A1 2-OXO-$i(2H)-QUINOLINE DERIVATIVES |
| 06/20/2001 | EP1107813A1 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures |
| 06/20/2001 | EP1107807A1 Method of enhancing catheter patency using a citrate salt catheter lock solution |
| 06/20/2001 | EP1107790A1 Targeting of molecules to large vessel endothelium using epcr |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107776A1 Dry extract of henna, method for producing said extract and use of the same |
| 06/20/2001 | EP1107755A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107722A2 A method for the treatment of staphylococcal disease |
| 06/20/2001 | EP1107702A1 Ultrasonic enhancement of drug injection |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300280A Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |